TY - JOUR
T1 - Hemodynamic and electrocardiographic effects of fructose-1,6-diphosphate in acute myocardial infarction
AU - Marchionni, Niccolò
AU - Conti, Alberto
AU - De Alfieri, Walter
AU - Di Bari, Mauro
AU - Ferrucci, Luigi
AU - Lombardi, Alessandra
AU - Moschi, Guya
AU - Pini, Riccardo
AU - Vannucci, Andrea
PY - 1985/8/1
Y1 - 1985/8/1
N2 - Acute hemodynamic and electrocardiographic effects of fructose-1,6-diphosphate (FDP), an agent that is supposed to restore anaerobic glycolitic flux in the ischemic myocardium, were studied in 40 patients with acute myocardial infarction who were grouped into 4 subsets: subset 1, normal (15 mm Hg or less) pulmonary artery (PA) wedge pressure and normal (35 g-m/m2 or greater) left ventricular (LV) stroke work index; subset 2, elevated (more than 15 mm Hg) PA wedge pressure and normal LV stroke work index; subset 3, normal PA wedge pressure and reduced (less than 35 g-m/m2) LV stroke work index; subset 4, elevated PA wedge pressure and LV stroke work index moderately reduced to a range between 16 and 34 g-m/m2. Patients were randomized into an FDP (250 mg/kg body weight in isotonic saline solution intravenously in 20 minutes) and into a placebo group. Each subset contained 5 FDP- and 5 placebo-treated patients. After basal measurements, hemodynamic measurements were reassessed at 60, 90 and 120 minutes from the infusions, while a standard 12-lead electrocardiogram was recorded in the basal state and 120 minutes after infusion. Nonsignificant hemodynamic change was observed in the placebo subsets, and FDP failed to exert any effect in subsets 1, 2 and 3. A 24% (p <0.02) increase in cardiac index occurred 60 minutes after FDP in subset 4. LV stroke work index also increased, while PA wedge pressure remained unchanged. Electrocardiographic markers of myocardial ischemia were not significantly reduced in any of the subsets, both in the control and in the treated group. Nevertheless, reduction was greater after FDP than after placebo administration in each subset, and it attained statistical significance when analyzed in the whole series of 20 FDP-treated patients. Two control patients died (1 from progressive LV failure) and 1 had a primary ventricular fibrillation successfully treated by direct-current shock. No FDP-treated patient died or had ventricular arrhythmias.
AB - Acute hemodynamic and electrocardiographic effects of fructose-1,6-diphosphate (FDP), an agent that is supposed to restore anaerobic glycolitic flux in the ischemic myocardium, were studied in 40 patients with acute myocardial infarction who were grouped into 4 subsets: subset 1, normal (15 mm Hg or less) pulmonary artery (PA) wedge pressure and normal (35 g-m/m2 or greater) left ventricular (LV) stroke work index; subset 2, elevated (more than 15 mm Hg) PA wedge pressure and normal LV stroke work index; subset 3, normal PA wedge pressure and reduced (less than 35 g-m/m2) LV stroke work index; subset 4, elevated PA wedge pressure and LV stroke work index moderately reduced to a range between 16 and 34 g-m/m2. Patients were randomized into an FDP (250 mg/kg body weight in isotonic saline solution intravenously in 20 minutes) and into a placebo group. Each subset contained 5 FDP- and 5 placebo-treated patients. After basal measurements, hemodynamic measurements were reassessed at 60, 90 and 120 minutes from the infusions, while a standard 12-lead electrocardiogram was recorded in the basal state and 120 minutes after infusion. Nonsignificant hemodynamic change was observed in the placebo subsets, and FDP failed to exert any effect in subsets 1, 2 and 3. A 24% (p <0.02) increase in cardiac index occurred 60 minutes after FDP in subset 4. LV stroke work index also increased, while PA wedge pressure remained unchanged. Electrocardiographic markers of myocardial ischemia were not significantly reduced in any of the subsets, both in the control and in the treated group. Nevertheless, reduction was greater after FDP than after placebo administration in each subset, and it attained statistical significance when analyzed in the whole series of 20 FDP-treated patients. Two control patients died (1 from progressive LV failure) and 1 had a primary ventricular fibrillation successfully treated by direct-current shock. No FDP-treated patient died or had ventricular arrhythmias.
UR - http://www.scopus.com/inward/record.url?scp=0021857613&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021857613&partnerID=8YFLogxK
U2 - 10.1016/0002-9149(85)90847-1
DO - 10.1016/0002-9149(85)90847-1
M3 - Article
C2 - 4025164
AN - SCOPUS:0021857613
SN - 0002-9149
VL - 56
SP - 266
EP - 269
JO - The American Journal of Cardiology
JF - The American Journal of Cardiology
IS - 4
ER -